A- A A+
Last Updated : Aug 5 2020 7:09PM     Screen Reader Access
News Highlights
PM Modi performs Bhoomi Pujan and lays foundation stone of Ram Temple in Ayodhya            Ram Temple is a Symbol of Unity, says Prime Minister Modi            COVID-19 recovery rate reaches 67.19 pct; highest number of people recover in last 24 hours            Sushant Rajput death case: Centre accepts Bihar govt’s recommendation of CBI inquiry            Heavy rains throw life out of gear in Mumbai, Thane, Palghar districts of Maharashtra           

National News

Jul 07, 2020
1:50PM

Registration for human trials of Indian vaccine for Coronavirus begins today

@ICMRDELHI
Indian COVID 19 vaccines are in the global race to end the coronavirus pandemic. Indian Council of Medical Research (ICMR) had written to 12 Medical Institutes in the country to start the first phase of Human Clinical Trials by registering volunteers. Our Correspondent has reported that a maximum number of these Institutes have begun the subject enrolment process which was slated to be initiated today. ICMR has partnered with Bharat Biotech International Limited to develop COVAXIN, whereas Zydus Cadila is working on ZyCov-D Vaccine.

Drug Controller General of India recently gave nod to the human trial for both COVAXIN and ZyCov-D vaccines marking the beginning of an end to the global pandemic. Indian manufacturers account for 60 percent of vaccine supplies made to UNICEF. Across the world, more than 140 candidate vaccines are under various stages of development. Indian institutions have also engaged in Research and Development for the development of vaccines in India. With the beginning of enrollment of volunteers today, the two Indian vaccine candidates will now be tested on 1,125 healthy volunteers in the two phases of trials. The vaccines will be evaluated for its safety, reactogenicity, tolerability and immunogenicity. Volunteers will be administered two intramuscular shots. The proposed age groups for the trials are 18-55 years for Phase I and 12-65 years for Phase II. Anand Chaturvedi, AIR News, Delhi.

Dr. Rakesh Mishra, Director of Centre for Cellular and Molecular Biology, Hyderabad has urged people not to lower their guards amidst the scientific progress on vaccine development. Speaking exclusively to AIR News, Dr. Misha lauded the preemptive and timely approach of the government which he said, provided the required impetus for the scientific development in the country.

Live Twitter Feed

Listen News

Morning News 5 (Aug) Midday News 5 (Aug) Evening News 4 (Aug) Hourly 5 (Aug) (1800hrs)
समाचार प्रभात 5 (Aug) दोपहर समाचार 5 (Aug) समाचार संध्या 4 (Aug) प्रति घंटा समाचार 5 (Aug) (1810hrs)
Khabarnama (Mor) 5 (Aug) Khabrein(Day) 5 (Aug) Khabrein(Eve) 4 (Aug)
Aaj Savere 5 (Aug) Parikrama 5 (Aug)

Listen Programs

Market Mantra 4 (Aug) Samayki 4 (Aug) Sports Scan 23 (Mar) Spotlight/News Analysis 4 (Aug) Samachar Darshan 22 (Mar) Radio Newsreel 21 (Mar)
    Public Speak

    Country wide 12 (Mar) Surkhiyon Mein 29 (Jul) Charcha Ka Vishai Ha 11 (Mar) Vaad-Samvaad 17 (Mar) Money Talk 17 (Mar) Current Affairs 6 (Mar) Sanskrit Saptahiki 1 (Aug)
  • Money Matters 22 (Mar)
  • International News 22 (Mar)
  • Press Review 23 (Mar)
  • From the States 23 (Mar)
  • Let's Connect 22 (Mar)
  • 360°- Ek Parivesh 23 (Mar)
  • Know Your Constitution 30 (Jan)
  • Ek Bharat Shreshta Bharat 22 (Mar)
  • Sanskriti Darshan 23 (Mar)
  • Fit India New India 23 (Mar)
  • Weather Report 21 (Mar)
  • North East Diaries 22 (Mar)
  • 150 Years of Bapu 22 (Mar)
  • Sector Specific Discussions 22 (Mar)